个人中心 - 老虎社区

SDQwerty

IP属地：未知

帖子 · 13帖子 · 13
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- SDQwertySDQwerty
  ·2021-12-20
  Think too much and analyzed too deep.
  U.S. Stock Futures, Oil Prices Slump on Omicron Curbs
  U.S. stock futures, oil prices and bond yields fell as investors worried that a rise in Omicron Covi
  U.S. Stock Futures, Oil Prices Slump on Omicron Curbs
  888 1
  4
  分享
  举报
- SDQwertySDQwerty
  ·2021-12-17
  Lame
  10 Biggest Price Target Changes For Friday
  Piper Sandler boosted Accenture plc(NYSE:ACN) price target from $354 to $433. Accenture shares dropp
  10 Biggest Price Target Changes For Friday
  1,240 1
  6
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-22
  Hi
  Goldman Says Global Stock Markets Are Nowhere Near Risky Bubble
  Strategists say high valuation not necessarily a systemic risk Goldman note sees rally based on real
  Goldman Says Global Stock Markets Are Nowhere Near Risky Bubble
  277 3
  点赞
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-22
  Hi
  Toplines Before US Market Open on Monday
  U.S. stock futures were mixed on MondayThe 10-year U.S. Treasury yield drops below 1.7%U.S. stock fu
  Toplines Before US Market Open on Monday
  130 评论
  5
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-18
  Please like and comment :) haha
  非常抱歉，此主贴已删除
  240 2
  1
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-18
  Sad
  非常抱歉，此主贴已删除
  285 评论
  1
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-18
  Hi come on
  Legend Biotech EPS beats by $0.08, beats on revenue
  (March 18) Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business U
  Legend Biotech EPS beats by $0.08, beats on revenue
  293 评论
  点赞
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-18
  Please please
  非常抱歉，此主贴已删除
  183 3
  点赞
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-17
  This is so cool
  16 small-cap stocks that could get a boost from ETF buying
  The Russell family of indexes will add several newly-public companies in March, at which point excha
  16 small-cap stocks that could get a boost from ETF buying
  370 评论
  2
  分享
  举报
- SDQwertySDQwerty
  ·2021-03-17
  Hi
  WTI Extends Losses As Crude Stocks Surge To 4-Month Highs
  Oil prices rollercoastered overnight, rallying on the surpriseAPI-reported crude drawand then slumpi
  WTI Extends Losses As Crude Stocks Surge To 4-Month Highs
  177 评论
  2
  分享
  举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3561701296039483","uuid":"3561701296039483","gmtCreate":1598607314924,"gmtModify":1639998155423,"name":"SDQwerty","pinyin":"sdqwerty","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":37,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.20%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":693833263,"gmtCreate":1639996917583,"gmtModify":1639997275439,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Think too much and analyzed too deep.&nbsp;","listText":"Think too much and analyzed too deep.&nbsp;","text":"Think too much and analyzed too deep.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693833263","repostId":"1108294147","repostType":4,"repost":{"id":"1108294147","pubTimestamp":1639996490,"share":"https://www.laohu8.com/m/news/1108294147?lang=&edition=full","pubTime":"2021-12-20 18:34","market":"us","language":"en","title":"U.S. Stock Futures, Oil Prices Slump on Omicron Curbs","url":"https://stock-news.laohu8.com/highlight/detail?id=1108294147","media":"Wall Street Journal","summary":"U.S. stock futures, oil prices and bond yields fell as investors worried that a rise in Omicron Covi","content":"<p>U.S. stock futures, oil prices and bond yields fell as investors worried that a rise in Omicron Covid-19 cases would stall economic growth and add pressure to inflation.</p>\n<p>Futures for the S&amp;P 500 tumbled 1.8% Monday. The index&nbsp;fell Friday, notching its largest weekly percentage decline in three weeks. Contracts for the tech-focused Nasdaq-100 shed 1.7% Monday, and futures for the Dow Jones Industrial Average declined 1.7%.</p>\n<p>Some countries are&nbsp;imposing restrictions&nbsp;to stem the spread of the Omicron variant as the holiday season starts. The Netherlands on Sunday reimposed a lockdown, with all nonessential shops, bars and restaurants closed until mid-January. Irish Prime Minister Micheál Martin also announced new restrictions. President Biden plans to deliver an update Tuesday on the fight against Covid-19 in the U.S., where cases are rising.</p>\n<p>The rise in infections has prompted concerns that a new wave is likely to prolong supply-chain disruptions that have&nbsp;elevated inflation.</p>\n<p>“We’re really seeing Omicron spread like wildfire, and it’s weighing on sentiment,” said Esty Dwek, chief investment officer at FlowBank. “You’re seeing lockdowns instigated in Europe. You’re seeing more and more restrictions and the number of cases is going up so much that even if it’s less severe it could lead to more hospitalizations,” which are likely to cause new restrictions that will weigh on growth, she added.</p>\n<p>Oil prices fell amid concerns that the spread of the Omicron variant could hurt global economic growth and crimp oil demand. Brent crude futures, the benchmark in global oil markets, declined 5.1% to $69.78 a barrel.</p>\n<p>In bond markets, the yield on the benchmark 10-year Treasury note ticked down to 1.368% Monday from 1.401% Friday. Investors tend to buy government bonds, seen as one of the safest assets to hold, in times of uncertainty, causing bond prices to rise and yields to fall.</p>\n<p>The Cboe Volatility Index—Wall Street’s so-called fear gauge, also known as the VIX—ticked up to 27.20, its highest level in two weeks.</p>\n<p>In premarket trading, shares of cruise companies sank, with&nbsp;Norwegian Cruise Line&nbsp;and Carnival down more than 5% each. Shares of energy companies slipped alongside oil prices.&nbsp;Occidental Petroleum&nbsp;shares fell 5.4% and&nbsp;Marathon Oil&nbsp;declined 4.7%.</p>\n<p>Portfolio managers whose performance is assessed on a year-over-year basis are also likely closing out their positions and locking in gains after a strong year in markets. Despite recent market volatility, the S&amp;P 500 is up more than 20% this year.</p>\n<p>Also weighing on sentiment, Sen. Joe Manchin (D., W.Va.) said he would oppose his party’s roughly $2 trillion education, healthcare and climate package, likely&nbsp;dooming the centerpiece of Mr. Biden’s economic agenda&nbsp;as currently written.</p>\n<p>Overseas, the pan-continental Stoxx Europe 600 tumbled 2.5%. Shares of U.K. food-delivery companyDeliverooadded 3.5% in London trading.</p>\n<p>Major indexes in Asia closed lower. South Korea’s Kospi contracted 1.8% and Japan’s Nikkei 225 shed 2.1%. Hong Kong’s flagship Hang Seng Index fell 1.9% to its lowest closing level since March 2020, according to FactSet.</p>\n<p>China’s Shanghai Composite declined 1.1%. China’s central bank&nbsp;cut the one-year loan prime rate&nbsp;amid a slowing economy that has been dragged by a slump in the property sector.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stock Futures, Oil Prices Slump on Omicron Curbs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stock Futures, Oil Prices Slump on Omicron Curbs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 18:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/global-stock-markets-dow-update-12-20-2021-11639989846?mod=markets_lead_pos1><strong>Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stock futures, oil prices and bond yields fell as investors worried that a rise in Omicron Covid-19 cases would stall economic growth and add pressure to inflation.\nFutures for the S&P 500 ...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-20-2021-11639989846?mod=markets_lead_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-20-2021-11639989846?mod=markets_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108294147","content_text":"U.S. stock futures, oil prices and bond yields fell as investors worried that a rise in Omicron Covid-19 cases would stall economic growth and add pressure to inflation.\nFutures for the S&P 500 tumbled 1.8% Monday. The index fell Friday, notching its largest weekly percentage decline in three weeks. Contracts for the tech-focused Nasdaq-100 shed 1.7% Monday, and futures for the Dow Jones Industrial Average declined 1.7%.\nSome countries are imposing restrictions to stem the spread of the Omicron variant as the holiday season starts. The Netherlands on Sunday reimposed a lockdown, with all nonessential shops, bars and restaurants closed until mid-January. Irish Prime Minister Micheál Martin also announced new restrictions. President Biden plans to deliver an update Tuesday on the fight against Covid-19 in the U.S., where cases are rising.\nThe rise in infections has prompted concerns that a new wave is likely to prolong supply-chain disruptions that have elevated inflation.\n“We’re really seeing Omicron spread like wildfire, and it’s weighing on sentiment,” said Esty Dwek, chief investment officer at FlowBank. “You’re seeing lockdowns instigated in Europe. You’re seeing more and more restrictions and the number of cases is going up so much that even if it’s less severe it could lead to more hospitalizations,” which are likely to cause new restrictions that will weigh on growth, she added.\nOil prices fell amid concerns that the spread of the Omicron variant could hurt global economic growth and crimp oil demand. Brent crude futures, the benchmark in global oil markets, declined 5.1% to $69.78 a barrel.\nIn bond markets, the yield on the benchmark 10-year Treasury note ticked down to 1.368% Monday from 1.401% Friday. Investors tend to buy government bonds, seen as one of the safest assets to hold, in times of uncertainty, causing bond prices to rise and yields to fall.\nThe Cboe Volatility Index—Wall Street’s so-called fear gauge, also known as the VIX—ticked up to 27.20, its highest level in two weeks.\nIn premarket trading, shares of cruise companies sank, with Norwegian Cruise Line and Carnival down more than 5% each. Shares of energy companies slipped alongside oil prices. Occidental Petroleum shares fell 5.4% and Marathon Oil declined 4.7%.\nPortfolio managers whose performance is assessed on a year-over-year basis are also likely closing out their positions and locking in gains after a strong year in markets. Despite recent market volatility, the S&P 500 is up more than 20% this year.\nAlso weighing on sentiment, Sen. Joe Manchin (D., W.Va.) said he would oppose his party’s roughly $2 trillion education, healthcare and climate package, likely dooming the centerpiece of Mr. Biden’s economic agenda as currently written.\nOverseas, the pan-continental Stoxx Europe 600 tumbled 2.5%. Shares of U.K. food-delivery companyDeliverooadded 3.5% in London trading.\nMajor indexes in Asia closed lower. South Korea’s Kospi contracted 1.8% and Japan’s Nikkei 225 shed 2.1%. Hong Kong’s flagship Hang Seng Index fell 1.9% to its lowest closing level since March 2020, according to FactSet.\nChina’s Shanghai Composite declined 1.1%. China’s central bank cut the one-year loan prime rate amid a slowing economy that has been dragged by a slump in the property sector.","news_type":1},"isVote":1,"tweetType":1,"viewCount":888,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699303496,"gmtCreate":1639745236354,"gmtModify":1639745236354,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Lame","listText":"Lame","text":"Lame","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699303496","repostId":"1168257220","repostType":4,"repost":{"id":"1168257220","pubTimestamp":1639744121,"share":"https://www.laohu8.com/m/news/1168257220?lang=&edition=full","pubTime":"2021-12-17 20:28","market":"us","language":"en","title":"10 Biggest Price Target Changes For Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1168257220","media":"Benzinga","summary":"Piper Sandler boosted Accenture plc(NYSE:ACN) price target from $354 to $433. Accenture shares dropp","content":"<ul>\n <li>Piper Sandler boosted&nbsp;<b>Accenture plc</b>(NYSE:ACN) price target from $354 to $433. Accenture shares dropped 0.4% to $399.00 in pre-market trading.</li>\n <li>JP Morgan cut the price target on&nbsp;<b>Medtronic plc</b>(NYSE:MDT) from $130 to $105. Medtronic shares fell 0.9% to $101.26 in pre-market trading.</li>\n <li>Raymond James lifted the price target on&nbsp;<b>Jabil Inc.</b>(NYSE:JBL) from $70 to $80. Jabil shares fell 0.4% to $64.20 in pre-market trading.</li>\n <li>BMO Capital lowered the price target on&nbsp;<b>T. Rowe Price Group, Inc.</b>(NASDAQ:TROW) from $253 to $246. T. Rowe Price shares rose 1.2% to $192.99 in pre-market trading.</li>\n <li>Baird reduced the price target for&nbsp;<b>Starbucks Corporation</b>(NASDAQ:SBUX) from $126 to $116. Starbucks shares dropped 1.7% to $111.71 in pre-market trading.</li>\n <li>SVB Leerink raised&nbsp;<b>Zentalis Pharmaceuticals, Inc.</b>(NASDAQ:ZNTL) price target from $89 to $97. Zentalis Pharmaceuticals shares fell 3.4% to $76.57 in pre-market trading.</li>\n <li>Piper Sandler cut&nbsp;<b>Adobe Inc.</b>(NASDAQ:ADBE) price target from $670 to $630. Adobe shares fell 0.8% to $561.80 in pre-market trading.</li>\n <li>Keybanc reduced the price target for&nbsp;<b>Generac Holdings Inc.</b>(NYSE:GNRC) from $540 to $500. Generac Holdings shares rose 3% to $360.40 in pre-market trading.</li>\n <li>Needham cut&nbsp;<b>Jazz Pharmaceuticals plc</b>(NASDAQ:JAZZ) price target from $220 to $215. Jazz Pharmaceuticals shares fell 0.4% to $124.00 in pre-market trading.</li>\n <li>JP Morgan boosted&nbsp;<b>Chipotle Mexican Grill, Inc.</b>(NYSE:CMG) price target from $1,710 to $1,750. Chipotle shares fell 1.3% to close at $1,678.97 on Thursday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 20:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/price-target/21/12/24666359/10-biggest-price-target-changes-for-friday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Piper Sandler boosted Accenture plc(NYSE:ACN) price target from $354 to $433. Accenture shares dropped 0.4% to $399.00 in pre-market trading.\nJP Morgan cut the price target on Medtronic plc(NYSE:MDT) ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/price-target/21/12/24666359/10-biggest-price-target-changes-for-friday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACN":"埃森哲","SBUX":"星巴克","ADBE":"Adobe"},"source_url":"https://www.benzinga.com/analyst-ratings/price-target/21/12/24666359/10-biggest-price-target-changes-for-friday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168257220","content_text":"Piper Sandler boosted Accenture plc(NYSE:ACN) price target from $354 to $433. Accenture shares dropped 0.4% to $399.00 in pre-market trading.\nJP Morgan cut the price target on Medtronic plc(NYSE:MDT) from $130 to $105. Medtronic shares fell 0.9% to $101.26 in pre-market trading.\nRaymond James lifted the price target on Jabil Inc.(NYSE:JBL) from $70 to $80. Jabil shares fell 0.4% to $64.20 in pre-market trading.\nBMO Capital lowered the price target on T. Rowe Price Group, Inc.(NASDAQ:TROW) from $253 to $246. T. Rowe Price shares rose 1.2% to $192.99 in pre-market trading.\nBaird reduced the price target for Starbucks Corporation(NASDAQ:SBUX) from $126 to $116. Starbucks shares dropped 1.7% to $111.71 in pre-market trading.\nSVB Leerink raised Zentalis Pharmaceuticals, Inc.(NASDAQ:ZNTL) price target from $89 to $97. Zentalis Pharmaceuticals shares fell 3.4% to $76.57 in pre-market trading.\nPiper Sandler cut Adobe Inc.(NASDAQ:ADBE) price target from $670 to $630. Adobe shares fell 0.8% to $561.80 in pre-market trading.\nKeybanc reduced the price target for Generac Holdings Inc.(NYSE:GNRC) from $540 to $500. Generac Holdings shares rose 3% to $360.40 in pre-market trading.\nNeedham cut Jazz Pharmaceuticals plc(NASDAQ:JAZZ) price target from $220 to $215. Jazz Pharmaceuticals shares fell 0.4% to $124.00 in pre-market trading.\nJP Morgan boosted Chipotle Mexican Grill, Inc.(NYSE:CMG) price target from $1,710 to $1,750. Chipotle shares fell 1.3% to close at $1,678.97 on Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":359574018,"gmtCreate":1616417214034,"gmtModify":1634525960036,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/359574018","repostId":"1145697272","repostType":4,"repost":{"id":"1145697272","pubTimestamp":1616417060,"share":"https://www.laohu8.com/m/news/1145697272?lang=&edition=full","pubTime":"2021-03-22 20:44","market":"us","language":"en","title":"Goldman Says Global Stock Markets Are Nowhere Near Risky Bubble","url":"https://stock-news.laohu8.com/highlight/detail?id=1145697272","media":"Bloomberg","summary":"Strategists say high valuation not necessarily a systemic risk\nGoldman note sees rally based on real","content":"<ul>\n <li>Strategists say high valuation not necessarily a systemic risk</li>\n <li>Goldman note sees rally based on reality, rather than hope</li>\n</ul>\n<p>While equities across major markets are hovering around record highs, Goldman Sachs Group Inc. strategists say many of the characteristics of a dangerous bubble are absent from global stocks.</p>\n<p>Typical signs of systemic risk, such as increased leverage in the private sector and a collapse in savings, aren’t present, the strategists led by Peter Oppenheimer wrote in a report to clients on Monday. Moreover, the rally is unfolding against the backdrop of market concentration in companies that are fast-growing, generate cash and transform their industry, such as major technology businesses, they added.</p>\n<p>“There are signs of complacency and heightened optimism in the market,” the Goldman strategists wrote in the 46-page report titled “Bubble Puzzle.” “Nevertheless, the fundamental factors that drive the market and the early stage of the economic cycle would suggest that we are far away from a bubble or bear market.”</p>\n<p>European stocks rose last week to their highest in a year, despite prolonged lockdowns and delays in the continent’s vaccination rollout, which could delay a nascent recovery from the steepest recession in memory. In the U.S., the S&amp;P 500 rose to another record high last week.</p>\n<p>Still, not everything is fine. The analysts see “pockets of exuberance,” while “high valuations imply lower longer-term returns.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Says Global Stock Markets Are Nowhere Near Risky Bubble</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Says Global Stock Markets Are Nowhere Near Risky Bubble\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-22 20:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://bloomberg.com/news/articles/2021-03-22/goldman-says-global-stock-markets-are-nowhere-near-risky-bubble?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Strategists say high valuation not necessarily a systemic risk\nGoldman note sees rally based on reality, rather than hope\n\nWhile equities across major markets are hovering around record highs, Goldman...</p>\n\n<a href=\"http://bloomberg.com/news/articles/2021-03-22/goldman-says-global-stock-markets-are-nowhere-near-risky-bubble?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"http://bloomberg.com/news/articles/2021-03-22/goldman-says-global-stock-markets-are-nowhere-near-risky-bubble?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145697272","content_text":"Strategists say high valuation not necessarily a systemic risk\nGoldman note sees rally based on reality, rather than hope\n\nWhile equities across major markets are hovering around record highs, Goldman Sachs Group Inc. strategists say many of the characteristics of a dangerous bubble are absent from global stocks.\nTypical signs of systemic risk, such as increased leverage in the private sector and a collapse in savings, aren’t present, the strategists led by Peter Oppenheimer wrote in a report to clients on Monday. Moreover, the rally is unfolding against the backdrop of market concentration in companies that are fast-growing, generate cash and transform their industry, such as major technology businesses, they added.\n“There are signs of complacency and heightened optimism in the market,” the Goldman strategists wrote in the 46-page report titled “Bubble Puzzle.” “Nevertheless, the fundamental factors that drive the market and the early stage of the economic cycle would suggest that we are far away from a bubble or bear market.”\nEuropean stocks rose last week to their highest in a year, despite prolonged lockdowns and delays in the continent’s vaccination rollout, which could delay a nascent recovery from the steepest recession in memory. In the U.S., the S&P 500 rose to another record high last week.\nStill, not everything is fine. The analysts see “pockets of exuberance,” while “high valuations imply lower longer-term returns.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":359575455,"gmtCreate":1616417188177,"gmtModify":1634525960156,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/359575455","repostId":"1109447999","repostType":4,"repost":{"id":"1109447999","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1616415450,"share":"https://www.laohu8.com/m/news/1109447999?lang=&edition=full","pubTime":"2021-03-22 20:17","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1109447999","media":"Tiger Newspress","summary":"U.S. stock futures were mixed on MondayThe 10-year U.S. Treasury yield drops below 1.7%U.S. stock fu","content":"<ul><li>U.S. stock futures were mixed on Monday</li></ul><ul><li>The 10-year U.S.&nbsp;Treasury yield drops below 1.7%</li></ul><p>U.S. stock futures were mixed on Monday as investors continue to focus on the bond market following last week’s rise in bond yields.</p><p>Dow futures were trading 0.03% lower, S&amp;P futures were&nbsp;0.24% higher&nbsp;and Nasdaq futures were 0.85% higher at the time of writing.</p><p>The 10-year U.S. Treasury yield fell back to 1.67% from the highest levels in about 14 months. The Treasury market remains in sharp focus this week amid a slate of&nbsp;auctions&nbsp;and moves by the Fed to let a key bank capital exemption lapse.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b4d49688f36f46ffb9a5c5c5c0e76753\" tg-width=\"1080\" tg-height=\"338\" referrerpolicy=\"no-referrer\"><span>*Source FromTiger Trade, EST 08:09</span></p><p>On the earnings calendar today, So-Young (<b>SY</b>), Ebix (<b>EBIX</b>) and Cellcom (<b>CELJF</b>) will report before the bell, while Tencent Music Entertainment (<b>TME</b>), Synnex (<b>SNX</b>) and Viant Technology (<b>DSP</b>) will release their results after the market closes.</p><p><b>Stocks making the biggest moves in the premarket：</b></p><p><b>Tesla&nbsp;(TSLA) </b>– Tesla shares&nbsp;will hit $3,000 in 2025, according to a projection by ARK Invest founder Cathie Wood. If that prediction pans out, Tesla would be worth roughly $3.6 trillion. The stock jumped 4.3% in premarket trading.</p><p><b>Nio,Xpeng Motors and Li Auto&nbsp;-</b>&nbsp;According to IFR, Nio,Xpeng Motors and Li Auto have approached investment banks for listing in Hong Kong, citing people familiar with the matter. Nio shares&nbsp;jumped&nbsp;3%,Xpeng Motors&nbsp;stock&nbsp;rose&nbsp;1.9%&nbsp;and&nbsp;Li Auto&nbsp;stock gained&nbsp;1%&nbsp;in pre-market trading.</p><p><b>RLX Technology</b>&nbsp;<b>-&nbsp;</b>Two of China's regulators plan to bring the rules governing the sale of e-cigarettes and other new tobacco products in line with those for ordinary cigarettes.The stock plunged 39% in pre-market trading.</p><p><b>AstraZeneca</b>&nbsp;<b>(AZN)</b> – The drugmaker said a U.S. study showed its Covid-19 vaccine&nbsp;had 79% efficacy in preventing symptomatic illness, 100% effectiveness against critical disease and hospitalization, and did not pose a higher risk of blood clots. AstraZeneca shares gained 2.5% in premarket trading.</p><p><b>Airbnb</b>&nbsp;<b>(ABNB)</b> – Airbnb shares rose 1.6% in premarket trading as more Americans receive Covid-19 vaccines and resume their travel plans.</p><p><b>Dada Group(DADA)</b>&nbsp;-&nbsp;JD.com,and Dada Group&nbsp;today jointly announced that JD.com, through its subsidiary, entered into a share purchase agreement with Dada, under which JD.com has agreed to invest a total of US$800 million in newly issued ordinary shares of Dada.The stock jumped 10% in premarket trading.</p><p><b>Blackstone</b>&nbsp;<b>(BX) </b>– Blackstone&nbsp;proposed a $6.2 billion buyout&nbsp;of Australian casino operator Crown Resorts. The stock rose above the offer price in Australian trading, signaling investor bets that a higher bid could come from another suitor.</p><p><b>Kansas City Southern&nbsp;(KSU) </b>– The railroad operator agreed to be bought by&nbsp;Canadian Pacific Railway&nbsp;(CP)&nbsp;in a $25 billion cash-and-stock deal. The transaction is worth $275 per share, compared to Kansas City Southern’s Friday closing price of $224.16. Kansas City Southern surged 17.8% in premarket action, while Canadian Pacific slid 2.8%.</p><p><b>PepsiCo&nbsp;(PEP)</b> – The beverage and snack giant’s stock rose 1% in the premarket after Barclays upgraded it to “overweight” from “equal weight.” Barclays noted recent underperformance by the stock and the potential for accelerating revenue and profit growth.</p><p><b>Stellantis</b>&nbsp;<b>(STLA)</b> – The automaker said a global semiconductor shortage would impact production of its popular pickup trucks, in a delay the parent of Chrysler and Jeep said could last “a number of weeks.”</p><p><b>Royal Caribbean(RCL)</b> – Royal Caribbean will restart some Caribbean cruises in June, following a year-long suspension amid the Covid-19 pandemic. Crews will be fully vaccinated, and adult guests will be required to be vaccinated as well. Children under 18 will need to show proof of a negative Covid test.</p><p><b>SunRun</b>&nbsp;<b>(RUN) </b>– The solar power company was rated “positive” in new coverage at Susquehanna Financial, with the firm saying the largest U.S. installer of residential solar power systems would benefit from anticipated strong growth in that market. Shares rose 1.9% in premarket trading.</p><p><b>Zoominfo Technologies</b>&nbsp;<b>(ZI)</b> – Goldman Sachs rated the digital ad technology platform provider as a “buy” in new coverage, noting the robust data provided to sales reps and the streamlining of the lead generation process. Zoominfo stock gained 2.5% in premarket action.</p><p><b>JetBlue&nbsp;(JBLU)</b> – The airline is planning to raise $650 million through the sale of convertible senior notes due in 2026. The stock fell 2% in premarket action.</p><p><b>DraftKings&nbsp;(DKNG) </b>– The sports betting company’s stock rose 2.1% in the premarket after Loop Capital repeated its call for DraftKings as “top pick,” noting that New York is poised to legalize online gambling and that the state’s market will be less competitive for DraftKings than New Jersey.</p><p><b>These are some key events to watch&nbsp;this week:</b></p><ul><li>Fed Chair Powell is due Monday at the BIS Innovation Summit. The ECB’s Christine Lagarde, BOE’s Andrew Bailey and chiefs of Sweden, Canada, Mexico and Brazil all follow.</li><li>Powell and Treasury Secretary Janet Yellen are expected to make their first joint appearance before the U.S. House Financial Services committee to testify on Fed and Treasury pandemic policies Tuesday.</li><li>The U.S. Treasury holds auctions of two-, five- and seven-year debt.</li><li>EIA crude oil inventory report on Wednesday.</li><li>On Friday, February U.S. personal income and spending data arrives.</li></ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-22 20:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul><li>U.S. stock futures were mixed on Monday</li></ul><ul><li>The 10-year U.S.&nbsp;Treasury yield drops below 1.7%</li></ul><p>U.S. stock futures were mixed on Monday as investors continue to focus on the bond market following last week’s rise in bond yields.</p><p>Dow futures were trading 0.03% lower, S&amp;P futures were&nbsp;0.24% higher&nbsp;and Nasdaq futures were 0.85% higher at the time of writing.</p><p>The 10-year U.S. Treasury yield fell back to 1.67% from the highest levels in about 14 months. The Treasury market remains in sharp focus this week amid a slate of&nbsp;auctions&nbsp;and moves by the Fed to let a key bank capital exemption lapse.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b4d49688f36f46ffb9a5c5c5c0e76753\" tg-width=\"1080\" tg-height=\"338\" referrerpolicy=\"no-referrer\"><span>*Source FromTiger Trade, EST 08:09</span></p><p>On the earnings calendar today, So-Young (<b>SY</b>), Ebix (<b>EBIX</b>) and Cellcom (<b>CELJF</b>) will report before the bell, while Tencent Music Entertainment (<b>TME</b>), Synnex (<b>SNX</b>) and Viant Technology (<b>DSP</b>) will release their results after the market closes.</p><p><b>Stocks making the biggest moves in the premarket：</b></p><p><b>Tesla&nbsp;(TSLA) </b>– Tesla shares&nbsp;will hit $3,000 in 2025, according to a projection by ARK Invest founder Cathie Wood. If that prediction pans out, Tesla would be worth roughly $3.6 trillion. The stock jumped 4.3% in premarket trading.</p><p><b>Nio,Xpeng Motors and Li Auto&nbsp;-</b>&nbsp;According to IFR, Nio,Xpeng Motors and Li Auto have approached investment banks for listing in Hong Kong, citing people familiar with the matter. Nio shares&nbsp;jumped&nbsp;3%,Xpeng Motors&nbsp;stock&nbsp;rose&nbsp;1.9%&nbsp;and&nbsp;Li Auto&nbsp;stock gained&nbsp;1%&nbsp;in pre-market trading.</p><p><b>RLX Technology</b>&nbsp;<b>-&nbsp;</b>Two of China's regulators plan to bring the rules governing the sale of e-cigarettes and other new tobacco products in line with those for ordinary cigarettes.The stock plunged 39% in pre-market trading.</p><p><b>AstraZeneca</b>&nbsp;<b>(AZN)</b> – The drugmaker said a U.S. study showed its Covid-19 vaccine&nbsp;had 79% efficacy in preventing symptomatic illness, 100% effectiveness against critical disease and hospitalization, and did not pose a higher risk of blood clots. AstraZeneca shares gained 2.5% in premarket trading.</p><p><b>Airbnb</b>&nbsp;<b>(ABNB)</b> – Airbnb shares rose 1.6% in premarket trading as more Americans receive Covid-19 vaccines and resume their travel plans.</p><p><b>Dada Group(DADA)</b>&nbsp;-&nbsp;JD.com,and Dada Group&nbsp;today jointly announced that JD.com, through its subsidiary, entered into a share purchase agreement with Dada, under which JD.com has agreed to invest a total of US$800 million in newly issued ordinary shares of Dada.The stock jumped 10% in premarket trading.</p><p><b>Blackstone</b>&nbsp;<b>(BX) </b>– Blackstone&nbsp;proposed a $6.2 billion buyout&nbsp;of Australian casino operator Crown Resorts. The stock rose above the offer price in Australian trading, signaling investor bets that a higher bid could come from another suitor.</p><p><b>Kansas City Southern&nbsp;(KSU) </b>– The railroad operator agreed to be bought by&nbsp;Canadian Pacific Railway&nbsp;(CP)&nbsp;in a $25 billion cash-and-stock deal. The transaction is worth $275 per share, compared to Kansas City Southern’s Friday closing price of $224.16. Kansas City Southern surged 17.8% in premarket action, while Canadian Pacific slid 2.8%.</p><p><b>PepsiCo&nbsp;(PEP)</b> – The beverage and snack giant’s stock rose 1% in the premarket after Barclays upgraded it to “overweight” from “equal weight.” Barclays noted recent underperformance by the stock and the potential for accelerating revenue and profit growth.</p><p><b>Stellantis</b>&nbsp;<b>(STLA)</b> – The automaker said a global semiconductor shortage would impact production of its popular pickup trucks, in a delay the parent of Chrysler and Jeep said could last “a number of weeks.”</p><p><b>Royal Caribbean(RCL)</b> – Royal Caribbean will restart some Caribbean cruises in June, following a year-long suspension amid the Covid-19 pandemic. Crews will be fully vaccinated, and adult guests will be required to be vaccinated as well. Children under 18 will need to show proof of a negative Covid test.</p><p><b>SunRun</b>&nbsp;<b>(RUN) </b>– The solar power company was rated “positive” in new coverage at Susquehanna Financial, with the firm saying the largest U.S. installer of residential solar power systems would benefit from anticipated strong growth in that market. Shares rose 1.9% in premarket trading.</p><p><b>Zoominfo Technologies</b>&nbsp;<b>(ZI)</b> – Goldman Sachs rated the digital ad technology platform provider as a “buy” in new coverage, noting the robust data provided to sales reps and the streamlining of the lead generation process. Zoominfo stock gained 2.5% in premarket action.</p><p><b>JetBlue&nbsp;(JBLU)</b> – The airline is planning to raise $650 million through the sale of convertible senior notes due in 2026. The stock fell 2% in premarket action.</p><p><b>DraftKings&nbsp;(DKNG) </b>– The sports betting company’s stock rose 2.1% in the premarket after Loop Capital repeated its call for DraftKings as “top pick,” noting that New York is poised to legalize online gambling and that the state’s market will be less competitive for DraftKings than New Jersey.</p><p><b>These are some key events to watch&nbsp;this week:</b></p><ul><li>Fed Chair Powell is due Monday at the BIS Innovation Summit. The ECB’s Christine Lagarde, BOE’s Andrew Bailey and chiefs of Sweden, Canada, Mexico and Brazil all follow.</li><li>Powell and Treasury Secretary Janet Yellen are expected to make their first joint appearance before the U.S. House Financial Services committee to testify on Fed and Treasury pandemic policies Tuesday.</li><li>The U.S. Treasury holds auctions of two-, five- and seven-year debt.</li><li>EIA crude oil inventory report on Wednesday.</li><li>On Friday, February U.S. personal income and spending data arrives.</li></ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","XPEV":"小鹏汽车","ABNB":"爱彼迎","NIO":"蔚来","RLX":"雾芯科技","LI":"理想汽车",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109447999","content_text":"U.S. stock futures were mixed on MondayThe 10-year U.S. Treasury yield drops below 1.7%U.S. stock futures were mixed on Monday as investors continue to focus on the bond market following last week’s rise in bond yields.Dow futures were trading 0.03% lower, S&P futures were 0.24% higher and Nasdaq futures were 0.85% higher at the time of writing.The 10-year U.S. Treasury yield fell back to 1.67% from the highest levels in about 14 months. The Treasury market remains in sharp focus this week amid a slate of auctions and moves by the Fed to let a key bank capital exemption lapse.*Source FromTiger Trade, EST 08:09On the earnings calendar today, So-Young (SY), Ebix (EBIX) and Cellcom (CELJF) will report before the bell, while Tencent Music Entertainment (TME), Synnex (SNX) and Viant Technology (DSP) will release their results after the market closes.Stocks making the biggest moves in the premarket：Tesla (TSLA) – Tesla shares will hit $3,000 in 2025, according to a projection by ARK Invest founder Cathie Wood. If that prediction pans out, Tesla would be worth roughly $3.6 trillion. The stock jumped 4.3% in premarket trading.Nio,Xpeng Motors and Li Auto - According to IFR, Nio,Xpeng Motors and Li Auto have approached investment banks for listing in Hong Kong, citing people familiar with the matter. Nio shares jumped 3%,Xpeng Motors stock rose 1.9% and Li Auto stock gained 1% in pre-market trading.RLX Technology - Two of China's regulators plan to bring the rules governing the sale of e-cigarettes and other new tobacco products in line with those for ordinary cigarettes.The stock plunged 39% in pre-market trading.AstraZeneca (AZN) – The drugmaker said a U.S. study showed its Covid-19 vaccine had 79% efficacy in preventing symptomatic illness, 100% effectiveness against critical disease and hospitalization, and did not pose a higher risk of blood clots. AstraZeneca shares gained 2.5% in premarket trading.Airbnb (ABNB) – Airbnb shares rose 1.6% in premarket trading as more Americans receive Covid-19 vaccines and resume their travel plans.Dada Group(DADA) - JD.com,and Dada Group today jointly announced that JD.com, through its subsidiary, entered into a share purchase agreement with Dada, under which JD.com has agreed to invest a total of US$800 million in newly issued ordinary shares of Dada.The stock jumped 10% in premarket trading.Blackstone (BX) – Blackstone proposed a $6.2 billion buyout of Australian casino operator Crown Resorts. The stock rose above the offer price in Australian trading, signaling investor bets that a higher bid could come from another suitor.Kansas City Southern (KSU) – The railroad operator agreed to be bought by Canadian Pacific Railway (CP) in a $25 billion cash-and-stock deal. The transaction is worth $275 per share, compared to Kansas City Southern’s Friday closing price of $224.16. Kansas City Southern surged 17.8% in premarket action, while Canadian Pacific slid 2.8%.PepsiCo (PEP) – The beverage and snack giant’s stock rose 1% in the premarket after Barclays upgraded it to “overweight” from “equal weight.” Barclays noted recent underperformance by the stock and the potential for accelerating revenue and profit growth.Stellantis (STLA) – The automaker said a global semiconductor shortage would impact production of its popular pickup trucks, in a delay the parent of Chrysler and Jeep said could last “a number of weeks.”Royal Caribbean(RCL) – Royal Caribbean will restart some Caribbean cruises in June, following a year-long suspension amid the Covid-19 pandemic. Crews will be fully vaccinated, and adult guests will be required to be vaccinated as well. Children under 18 will need to show proof of a negative Covid test.SunRun (RUN) – The solar power company was rated “positive” in new coverage at Susquehanna Financial, with the firm saying the largest U.S. installer of residential solar power systems would benefit from anticipated strong growth in that market. Shares rose 1.9% in premarket trading.Zoominfo Technologies (ZI) – Goldman Sachs rated the digital ad technology platform provider as a “buy” in new coverage, noting the robust data provided to sales reps and the streamlining of the lead generation process. Zoominfo stock gained 2.5% in premarket action.JetBlue (JBLU) – The airline is planning to raise $650 million through the sale of convertible senior notes due in 2026. The stock fell 2% in premarket action.DraftKings (DKNG) – The sports betting company’s stock rose 2.1% in the premarket after Loop Capital repeated its call for DraftKings as “top pick,” noting that New York is poised to legalize online gambling and that the state’s market will be less competitive for DraftKings than New Jersey.These are some key events to watch this week:Fed Chair Powell is due Monday at the BIS Innovation Summit. The ECB’s Christine Lagarde, BOE’s Andrew Bailey and chiefs of Sweden, Canada, Mexico and Brazil all follow.Powell and Treasury Secretary Janet Yellen are expected to make their first joint appearance before the U.S. House Financial Services committee to testify on Fed and Treasury pandemic policies Tuesday.The U.S. Treasury holds auctions of two-, five- and seven-year debt.EIA crude oil inventory report on Wednesday.On Friday, February U.S. personal income and spending data arrives.","news_type":1},"isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327185561,"gmtCreate":1616070383953,"gmtModify":1634527401474,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Please like and comment :) haha","listText":"Please like and comment :) haha","text":"Please like and comment :) haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/327185561","repostId":"2120547581","repostType":4,"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327181573,"gmtCreate":1616069996092,"gmtModify":1634527403262,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/327181573","repostId":"1129139683","repostType":4,"isVote":1,"tweetType":1,"viewCount":285,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327181015,"gmtCreate":1616069930337,"gmtModify":1634527403620,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Hi come on","listText":"Hi come on","text":"Hi come on","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/327181015","repostId":"1141211447","repostType":4,"repost":{"id":"1141211447","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1616067847,"share":"https://www.laohu8.com/m/news/1141211447?lang=&edition=full","pubTime":"2021-03-18 19:44","market":"us","language":"en","title":"Legend Biotech EPS beats by $0.08, beats on revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1141211447","media":"Tiger Newspress","summary":"(March 18) Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business U","content":"<p>(March 18)&nbsp;Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update.</p>\n<ul>\n <li>Legend Biotech&nbsp;: Q4 GAAP EPS of -$0.22beats by $0.08.</li>\n <li>Revenue of $40.78M (+109.7% Y/Y)beats by $28.78M.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/03aed76701fd868589414ae62671e72a\" tg-width=\"685\" tg-height=\"498\"></p>\n<p><b>Financial Results for the Quarter and Year Ended December 31, 2020</b></p>\n<p>Cash and Cash Equivalents and time deposits:</p>\n<p>As of December 31, 2020, Legend Biotech had approximately $455.7 million of cash and cash equivalents and approximately $50.0 million in time deposits.</p>\n<p><b>Revenue</b></p>\n<p>Revenue for the three months ended December 31, 2020 was $40.8 million compared to $19.5 million for the three months ended December 31, 2019. The increase of $21.3 million was primarily due to revenue recognition of additional milestone payment achieved of higher amount pursuant to Legend Biotech’s agreement with Janssen and the associated constrained variable consideration is relieved. Revenue for the year ended December 31, 2020 was $75.7 million compared to $57.3 million for the year ended December 31, 2019. Similarly, the increase of $18.4 million for the year ended December 31, 2020 was primarily driven by revenue recognized from an additional milestone achieved of higher amount. Legend Biotech has not generated any revenue from product sales to date.</p>\n<p><b>Research and Development Expenses</b></p>\n<p>Research and development expenses for the three months ended December 31, 2020 were $66.9 million compared to $66.1 million for the three months ended December 31, 2019. This increase of $0.8 million was primarily due to an increase in employee benefit expense and research and development expense, net-off by a decrease in collaborative research and development expenses. Research and development expenses for the year ended December 31, 2020 was $232.2 million compared to $161.9 million for the year ended December 31, 2019 with a $70.3 million increase. The year-over-year increase was primarily due to a higher number of clinical trials, a higher number of patients enrolled in those trials and a higher number of research and development product candidates in the year ended December 31, 2020.</p>\n<p><b>Loss for the Period</b></p>\n<p>For the three months ended December 31, 2020, net loss was $57.8 million, or $0.22 per share, compared to a net loss of $63.9 million, or $0.32 per share, for the three months ended December 31, 2019. Net loss was $303.5 million, or $1.28 per share, for the year ended December 31, 2020 compared to $133.0 million, or $0.66 per share, for the year ended December 31, 2019.</p>\n<p>Key Upcoming Milestones</p>\n<ul>\n <li>Legend Biotech’s collaborator, Janssen, anticipates submitting a MAA for cilta-cel for the treatment of adults with RRMM to the EMA in the first half of 2021.</li>\n <li>Legend Biotech intends to use the data from the CARTIFAN-1 study in support of a regulatory submission to the China Center for Drug Evaluation (CDE) seeking approval of cilta-cel for the treatment of adults with RRMM. Legend Biotech expects the submission of the application to occur in the second half of 2021.</li>\n <li>Legend Biotech’s collaborator, Janssen, anticipates submitting a New Drug Application (NDA) to the Japan Ministry of Health, Labor and Welfare (JMHLW) in the second half of 2021 seeking approval of cilta-cel for the treatment of adults with RRMM.</li>\n <li>Legend Biotech expects to initiate its Phase 1 clinical trial of LB1901 in RR TCL inthe United Statesin 2021.</li>\n <li>Legend Biotech, in collaboration with Janssen, intends to present updated data from the CARTITUDE-1 and data from CARTITUDE-2 studies at major medical conferences in 2021.</li>\n <li>Legend Biotech anticipates supporting investigators with publishing a clinical data update from LEGEND-2 study in 2021.</li>\n</ul>\n<p>As the global COVID-19 pandemic continues to evolve, Legend Biotech has continuously monitored the situation in regards to its operations and has put significant measures in place to protect supply chain, operations, employees and the execution of clinical trials. Given the dynamic global situation, Legend Biotech notes that certain clinical trial timelines may be impacted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Legend Biotech EPS beats by $0.08, beats on revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegend Biotech EPS beats by $0.08, beats on revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-03-18 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(March 18)&nbsp;Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update.</p>\n<ul>\n <li>Legend Biotech&nbsp;: Q4 GAAP EPS of -$0.22beats by $0.08.</li>\n <li>Revenue of $40.78M (+109.7% Y/Y)beats by $28.78M.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/03aed76701fd868589414ae62671e72a\" tg-width=\"685\" tg-height=\"498\"></p>\n<p><b>Financial Results for the Quarter and Year Ended December 31, 2020</b></p>\n<p>Cash and Cash Equivalents and time deposits:</p>\n<p>As of December 31, 2020, Legend Biotech had approximately $455.7 million of cash and cash equivalents and approximately $50.0 million in time deposits.</p>\n<p><b>Revenue</b></p>\n<p>Revenue for the three months ended December 31, 2020 was $40.8 million compared to $19.5 million for the three months ended December 31, 2019. The increase of $21.3 million was primarily due to revenue recognition of additional milestone payment achieved of higher amount pursuant to Legend Biotech’s agreement with Janssen and the associated constrained variable consideration is relieved. Revenue for the year ended December 31, 2020 was $75.7 million compared to $57.3 million for the year ended December 31, 2019. Similarly, the increase of $18.4 million for the year ended December 31, 2020 was primarily driven by revenue recognized from an additional milestone achieved of higher amount. Legend Biotech has not generated any revenue from product sales to date.</p>\n<p><b>Research and Development Expenses</b></p>\n<p>Research and development expenses for the three months ended December 31, 2020 were $66.9 million compared to $66.1 million for the three months ended December 31, 2019. This increase of $0.8 million was primarily due to an increase in employee benefit expense and research and development expense, net-off by a decrease in collaborative research and development expenses. Research and development expenses for the year ended December 31, 2020 was $232.2 million compared to $161.9 million for the year ended December 31, 2019 with a $70.3 million increase. The year-over-year increase was primarily due to a higher number of clinical trials, a higher number of patients enrolled in those trials and a higher number of research and development product candidates in the year ended December 31, 2020.</p>\n<p><b>Loss for the Period</b></p>\n<p>For the three months ended December 31, 2020, net loss was $57.8 million, or $0.22 per share, compared to a net loss of $63.9 million, or $0.32 per share, for the three months ended December 31, 2019. Net loss was $303.5 million, or $1.28 per share, for the year ended December 31, 2020 compared to $133.0 million, or $0.66 per share, for the year ended December 31, 2019.</p>\n<p>Key Upcoming Milestones</p>\n<ul>\n <li>Legend Biotech’s collaborator, Janssen, anticipates submitting a MAA for cilta-cel for the treatment of adults with RRMM to the EMA in the first half of 2021.</li>\n <li>Legend Biotech intends to use the data from the CARTIFAN-1 study in support of a regulatory submission to the China Center for Drug Evaluation (CDE) seeking approval of cilta-cel for the treatment of adults with RRMM. Legend Biotech expects the submission of the application to occur in the second half of 2021.</li>\n <li>Legend Biotech’s collaborator, Janssen, anticipates submitting a New Drug Application (NDA) to the Japan Ministry of Health, Labor and Welfare (JMHLW) in the second half of 2021 seeking approval of cilta-cel for the treatment of adults with RRMM.</li>\n <li>Legend Biotech expects to initiate its Phase 1 clinical trial of LB1901 in RR TCL inthe United Statesin 2021.</li>\n <li>Legend Biotech, in collaboration with Janssen, intends to present updated data from the CARTITUDE-1 and data from CARTITUDE-2 studies at major medical conferences in 2021.</li>\n <li>Legend Biotech anticipates supporting investigators with publishing a clinical data update from LEGEND-2 study in 2021.</li>\n</ul>\n<p>As the global COVID-19 pandemic continues to evolve, Legend Biotech has continuously monitored the situation in regards to its operations and has put significant measures in place to protect supply chain, operations, employees and the execution of clinical trials. Given the dynamic global situation, Legend Biotech notes that certain clinical trial timelines may be impacted.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEGN":"传奇生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141211447","content_text":"(March 18) Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update.\n\nLegend Biotech : Q4 GAAP EPS of -$0.22beats by $0.08.\nRevenue of $40.78M (+109.7% Y/Y)beats by $28.78M.\n\n\nFinancial Results for the Quarter and Year Ended December 31, 2020\nCash and Cash Equivalents and time deposits:\nAs of December 31, 2020, Legend Biotech had approximately $455.7 million of cash and cash equivalents and approximately $50.0 million in time deposits.\nRevenue\nRevenue for the three months ended December 31, 2020 was $40.8 million compared to $19.5 million for the three months ended December 31, 2019. The increase of $21.3 million was primarily due to revenue recognition of additional milestone payment achieved of higher amount pursuant to Legend Biotech’s agreement with Janssen and the associated constrained variable consideration is relieved. Revenue for the year ended December 31, 2020 was $75.7 million compared to $57.3 million for the year ended December 31, 2019. Similarly, the increase of $18.4 million for the year ended December 31, 2020 was primarily driven by revenue recognized from an additional milestone achieved of higher amount. Legend Biotech has not generated any revenue from product sales to date.\nResearch and Development Expenses\nResearch and development expenses for the three months ended December 31, 2020 were $66.9 million compared to $66.1 million for the three months ended December 31, 2019. This increase of $0.8 million was primarily due to an increase in employee benefit expense and research and development expense, net-off by a decrease in collaborative research and development expenses. Research and development expenses for the year ended December 31, 2020 was $232.2 million compared to $161.9 million for the year ended December 31, 2019 with a $70.3 million increase. The year-over-year increase was primarily due to a higher number of clinical trials, a higher number of patients enrolled in those trials and a higher number of research and development product candidates in the year ended December 31, 2020.\nLoss for the Period\nFor the three months ended December 31, 2020, net loss was $57.8 million, or $0.22 per share, compared to a net loss of $63.9 million, or $0.32 per share, for the three months ended December 31, 2019. Net loss was $303.5 million, or $1.28 per share, for the year ended December 31, 2020 compared to $133.0 million, or $0.66 per share, for the year ended December 31, 2019.\nKey Upcoming Milestones\n\nLegend Biotech’s collaborator, Janssen, anticipates submitting a MAA for cilta-cel for the treatment of adults with RRMM to the EMA in the first half of 2021.\nLegend Biotech intends to use the data from the CARTIFAN-1 study in support of a regulatory submission to the China Center for Drug Evaluation (CDE) seeking approval of cilta-cel for the treatment of adults with RRMM. Legend Biotech expects the submission of the application to occur in the second half of 2021.\nLegend Biotech’s collaborator, Janssen, anticipates submitting a New Drug Application (NDA) to the Japan Ministry of Health, Labor and Welfare (JMHLW) in the second half of 2021 seeking approval of cilta-cel for the treatment of adults with RRMM.\nLegend Biotech expects to initiate its Phase 1 clinical trial of LB1901 in RR TCL inthe United Statesin 2021.\nLegend Biotech, in collaboration with Janssen, intends to present updated data from the CARTITUDE-1 and data from CARTITUDE-2 studies at major medical conferences in 2021.\nLegend Biotech anticipates supporting investigators with publishing a clinical data update from LEGEND-2 study in 2021.\n\nAs the global COVID-19 pandemic continues to evolve, Legend Biotech has continuously monitored the situation in regards to its operations and has put significant measures in place to protect supply chain, operations, employees and the execution of clinical trials. Given the dynamic global situation, Legend Biotech notes that certain clinical trial timelines may be impacted.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327183857,"gmtCreate":1616069844079,"gmtModify":1634527404100,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Please please&nbsp;","listText":"Please please&nbsp;","text":"Please please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/327183857","repostId":"1135447748","repostType":4,"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":324230653,"gmtCreate":1615993415772,"gmtModify":1703496142361,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"This is so cool","listText":"This is so cool","text":"This is so cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/324230653","repostId":"2120187580","repostType":4,"repost":{"id":"2120187580","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1615991880,"share":"https://www.laohu8.com/m/news/2120187580?lang=&edition=full","pubTime":"2021-03-17 22:38","market":"us","language":"en","title":"16 small-cap stocks that could get a boost from ETF buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2120187580","media":"Dow Jones","summary":"The Russell family of indexes will add several newly-public companies in March, at which point excha","content":"<p>The Russell family of indexes will add several newly-public companies in March, at which point exchange-traded funds that track the indexes will need to buy shares in those companies. That buying activity could provide a boost to share prices, according to an analysis from Jefferies.</p>\n<p>\"A number of names could see decent tailwind,\" the Jefferies analysts wrote. Those 16 stocks are in the table below, along with the number of days over which Jefferies calculates they will see buying pressure.</p>\n<p>There are some caveats.</p>\n<p>\"We are adding to the growing list of concerns regarding small-cap performance moving too far, too fast,\" the analysts explain.</p>\n<p>As of Friday's open, the Russell 2000 is up 8.7% in the year to date, compared to a flat showing for the S&amp;P 500 and a negative <a href=\"https://laohu8.com/S/AONE\">one</a> for the Nasdaq .</p>\n<p>What's more, companies have been rushing to go public at a pace not seen since 1997 -- eclipsing even the 1999-2000 dot-com bubble.</p>\n<p>\"When the IPO calendar has been this hot in the past, performance has cooled,\" Jefferies wrote. \"We don't see negative performance but Small does tend to lag over the subsequent 6 and 12 months as investors digest the new names.\"</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company and ticker</td>\n   <td>Days to buy</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MDWT\">Midwest Holding Inc.</a>MDWT</td>\n   <td>15.2</td>\n  </tr>\n  <tr>\n   <td>Olema Pharmaceuticals Inc. OLMA</td>\n   <td>14.2</td>\n  </tr>\n  <tr>\n   <td>Silverback TherapeuticsInc.SBTX</td>\n   <td>11.1</td>\n  </tr>\n  <tr>\n   <td>Kinnate Biopharma Inc.KNTE</td>\n   <td>11</td>\n  </tr>\n  <tr>\n   <td>Sigilon TherapeuticsSGTX</td>\n   <td>9.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FDMT\">4D Molecular Therapeutics</a> IncFDMT</td>\n   <td>9.3</td>\n  </tr>\n  <tr>\n   <td>Ortho Clinical Diagnostics HoldingsOCDX</td>\n   <td>9</td>\n  </tr>\n  <tr>\n   <td>Terns Pharmaceuticals Inc.TERN</td>\n   <td>8.5</td>\n  </tr>\n  <tr>\n   <td>Cullinan OncologyCGEM</td>\n   <td>7.5</td>\n  </tr>\n  <tr>\n   <td>Bolt Biotherapeutics Inc.BOLT</td>\n   <td>7.2</td>\n  </tr>\n  <tr>\n   <td>Vor BiopharmaVOR</td>\n   <td>6.8</td>\n  </tr>\n  <tr>\n   <td>NeximmuneNEXI</td>\n   <td>6.5</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MASS\">908 Devices Inc.</a>MASS</td>\n   <td>5.8</td>\n  </tr>\n  <tr>\n   <td>BioAtlaInc.BCAB</td>\n   <td>5.5</td>\n  </tr>\n  <tr>\n   <td>Talis BiomedicalTLIS</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Decibel Therapeutics Inc.DBTX</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Source: Jefferies</td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Jefferies explains that they calculated \"days to buy\" like so: \"We took the weight of each name across the Russell indexes, multiplied that by our best guess as to how many passive assets are pegged to each index to come up with dollars to buy. We then divide the dollars by its price to come up with shares to buy. We then took the average last 10-days of trading volume to determine the days to buy.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>16 small-cap stocks that could get a boost from ETF buying</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n16 small-cap stocks that could get a boost from ETF buying\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-17 22:38</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The Russell family of indexes will add several newly-public companies in March, at which point exchange-traded funds that track the indexes will need to buy shares in those companies. That buying activity could provide a boost to share prices, according to an analysis from Jefferies.</p>\n<p>\"A number of names could see decent tailwind,\" the Jefferies analysts wrote. Those 16 stocks are in the table below, along with the number of days over which Jefferies calculates they will see buying pressure.</p>\n<p>There are some caveats.</p>\n<p>\"We are adding to the growing list of concerns regarding small-cap performance moving too far, too fast,\" the analysts explain.</p>\n<p>As of Friday's open, the Russell 2000 is up 8.7% in the year to date, compared to a flat showing for the S&amp;P 500 and a negative <a href=\"https://laohu8.com/S/AONE\">one</a> for the Nasdaq .</p>\n<p>What's more, companies have been rushing to go public at a pace not seen since 1997 -- eclipsing even the 1999-2000 dot-com bubble.</p>\n<p>\"When the IPO calendar has been this hot in the past, performance has cooled,\" Jefferies wrote. \"We don't see negative performance but Small does tend to lag over the subsequent 6 and 12 months as investors digest the new names.\"</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company and ticker</td>\n   <td>Days to buy</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MDWT\">Midwest Holding Inc.</a>MDWT</td>\n   <td>15.2</td>\n  </tr>\n  <tr>\n   <td>Olema Pharmaceuticals Inc. OLMA</td>\n   <td>14.2</td>\n  </tr>\n  <tr>\n   <td>Silverback TherapeuticsInc.SBTX</td>\n   <td>11.1</td>\n  </tr>\n  <tr>\n   <td>Kinnate Biopharma Inc.KNTE</td>\n   <td>11</td>\n  </tr>\n  <tr>\n   <td>Sigilon TherapeuticsSGTX</td>\n   <td>9.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FDMT\">4D Molecular Therapeutics</a> IncFDMT</td>\n   <td>9.3</td>\n  </tr>\n  <tr>\n   <td>Ortho Clinical Diagnostics HoldingsOCDX</td>\n   <td>9</td>\n  </tr>\n  <tr>\n   <td>Terns Pharmaceuticals Inc.TERN</td>\n   <td>8.5</td>\n  </tr>\n  <tr>\n   <td>Cullinan OncologyCGEM</td>\n   <td>7.5</td>\n  </tr>\n  <tr>\n   <td>Bolt Biotherapeutics Inc.BOLT</td>\n   <td>7.2</td>\n  </tr>\n  <tr>\n   <td>Vor BiopharmaVOR</td>\n   <td>6.8</td>\n  </tr>\n  <tr>\n   <td>NeximmuneNEXI</td>\n   <td>6.5</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MASS\">908 Devices Inc.</a>MASS</td>\n   <td>5.8</td>\n  </tr>\n  <tr>\n   <td>BioAtlaInc.BCAB</td>\n   <td>5.5</td>\n  </tr>\n  <tr>\n   <td>Talis BiomedicalTLIS</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Decibel Therapeutics Inc.DBTX</td>\n   <td>5.0</td>\n  </tr>\n  <tr>\n   <td>Source: Jefferies</td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Jefferies explains that they calculated \"days to buy\" like so: \"We took the weight of each name across the Russell indexes, multiplied that by our best guess as to how many passive assets are pegged to each index to come up with dollars to buy. We then divide the dollars by its price to come up with shares to buy. We then took the average last 10-days of trading volume to determine the days to buy.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2120187580","content_text":"The Russell family of indexes will add several newly-public companies in March, at which point exchange-traded funds that track the indexes will need to buy shares in those companies. That buying activity could provide a boost to share prices, according to an analysis from Jefferies.\n\"A number of names could see decent tailwind,\" the Jefferies analysts wrote. Those 16 stocks are in the table below, along with the number of days over which Jefferies calculates they will see buying pressure.\nThere are some caveats.\n\"We are adding to the growing list of concerns regarding small-cap performance moving too far, too fast,\" the analysts explain.\nAs of Friday's open, the Russell 2000 is up 8.7% in the year to date, compared to a flat showing for the S&P 500 and a negative one for the Nasdaq .\nWhat's more, companies have been rushing to go public at a pace not seen since 1997 -- eclipsing even the 1999-2000 dot-com bubble.\n\"When the IPO calendar has been this hot in the past, performance has cooled,\" Jefferies wrote. \"We don't see negative performance but Small does tend to lag over the subsequent 6 and 12 months as investors digest the new names.\"\n\n\n\nCompany and ticker\nDays to buy\n\n\nMidwest Holding Inc.MDWT\n15.2\n\n\nOlema Pharmaceuticals Inc. OLMA\n14.2\n\n\nSilverback TherapeuticsInc.SBTX\n11.1\n\n\nKinnate Biopharma Inc.KNTE\n11\n\n\nSigilon TherapeuticsSGTX\n9.9\n\n\n4D Molecular Therapeutics IncFDMT\n9.3\n\n\nOrtho Clinical Diagnostics HoldingsOCDX\n9\n\n\nTerns Pharmaceuticals Inc.TERN\n8.5\n\n\nCullinan OncologyCGEM\n7.5\n\n\nBolt Biotherapeutics Inc.BOLT\n7.2\n\n\nVor BiopharmaVOR\n6.8\n\n\nNeximmuneNEXI\n6.5\n\n\n908 Devices Inc.MASS\n5.8\n\n\nBioAtlaInc.BCAB\n5.5\n\n\nTalis BiomedicalTLIS\n5.0\n\n\nDecibel Therapeutics Inc.DBTX\n5.0\n\n\nSource: Jefferies\n\n\n\n\nJefferies explains that they calculated \"days to buy\" like so: \"We took the weight of each name across the Russell indexes, multiplied that by our best guess as to how many passive assets are pegged to each index to come up with dollars to buy. We then divide the dollars by its price to come up with shares to buy. We then took the average last 10-days of trading volume to determine the days to buy.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":370,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":324294391,"gmtCreate":1615993262613,"gmtModify":1703496138551,"author":{"id":"3561701296039483","authorId":"3561701296039483","name":"SDQwerty","avatar":"https://static.tigerbbs.com/91dd9a7c9982bff6f674211becf77da3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561701296039483","authorIdStr":"3561701296039483"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/324294391","repostId":"1123606184","repostType":4,"repost":{"id":"1123606184","pubTimestamp":1615993187,"share":"https://www.laohu8.com/m/news/1123606184?lang=&edition=full","pubTime":"2021-03-17 22:59","market":"us","language":"en","title":"WTI Extends Losses As Crude Stocks Surge To 4-Month Highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1123606184","media":"zerohedge","summary":"Oil prices rollercoastered overnight, rallying on the surpriseAPI-reported crude drawand then slumpi","content":"<p>Oil prices rollercoastered overnight, rallying on the surpriseAPI-reported crude drawand then slumping during the EU session amid demand concerns (driven by the terrible vaccine rollout).</p>\n<blockquote>\n <i><b>\"The suspension [of AZN vaccines] will not do the bloc's economic and fuel recovery any favors,\"</b></i>said Stephen Brennock of oil broker PVM.\"The hope now is that Europe can get its sluggish vaccine rollout back on track.\"\n</blockquote>\n<p>Oil weakness was exacerbated by IEA's latest report that said<b>a supercycle was unlikely, demand won't return to pre-pandemic levels until 2023</b>and could peak earlier than previously thought.</p>\n<p>After the prior two weeks of record-breaking swings in inventories, this last week is expected to show only modest changes, with crude stocks sitting at their highest since early December.</p>\n<p><img src=\"https://static.tigerbbs.com/a177dc89a9ad1e13853ebd1c14fb86a0\" tg-width=\"500\" tg-height=\"263\"><i>Source: Bloomberg</i></p>\n<p><u><b>API</b></u></p>\n<ul>\n <li><p><b>Crude -1.00mm (+400k exp)</b></p></li>\n <li><p>Cushing</p></li>\n <li><p>Gasoline -930k (-1.4mm exp)</p></li>\n <li><p>Distillates +904k (-900k exp)</p></li>\n</ul>\n<p><u><b>DOE</b></u></p>\n<ul>\n <li><p><b>Crude +2.396mm (+400k exp)</b></p></li>\n <li><p>Cushing -624k</p></li>\n <li><p>Gasoline +472k (-1.4mm exp)</p></li>\n <li><p>Distillates +255k (-900k exp)</p></li>\n</ul>\n<p>Despite refinery utilization recovering from the weather chaos in Texas,<b>crude stocks increased last week</b>(significantly more than API and was expected).</p>\n<p><img src=\"https://static.tigerbbs.com/48977f9a7b5fdf47bf34c1a6b87128f2\" tg-width=\"500\" tg-height=\"285\"><i>Source: Bloomberg</i></p>\n<p>US Crude production has yet to accelerate along with higher prices and more rigs...</p>\n<p><img src=\"https://static.tigerbbs.com/01ecfe47bc9a425bb9001b0d5224d019\" tg-width=\"500\" tg-height=\"283\"></p>\n<p><i>Source: Bloomberg</i></p>\n<p>WTI hovered around $64.50 ahead of the official inventory data and reversed its rebound on the print...</p>\n<p><img src=\"https://static.tigerbbs.com/9954849cefad34cd55e9e0fe26275086\" tg-width=\"500\" tg-height=\"305\">On the bright side, that $3.00 nation gas price may be avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WTI Extends Losses As Crude Stocks Surge To 4-Month Highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWTI Extends Losses As Crude Stocks Surge To 4-Month Highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-17 22:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/energy/wti-extends-losses-crude-stocks-surge-4-month-highs><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oil prices rollercoastered overnight, rallying on the surpriseAPI-reported crude drawand then slumping during the EU session amid demand concerns (driven by the terrible vaccine rollout).\n\n\"The ...</p>\n\n<a href=\"https://www.zerohedge.com/energy/wti-extends-losses-crude-stocks-surge-4-month-highs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.zerohedge.com/energy/wti-extends-losses-crude-stocks-surge-4-month-highs","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123606184","content_text":"Oil prices rollercoastered overnight, rallying on the surpriseAPI-reported crude drawand then slumping during the EU session amid demand concerns (driven by the terrible vaccine rollout).\n\n\"The suspension [of AZN vaccines] will not do the bloc's economic and fuel recovery any favors,\"said Stephen Brennock of oil broker PVM.\"The hope now is that Europe can get its sluggish vaccine rollout back on track.\"\n\nOil weakness was exacerbated by IEA's latest report that saida supercycle was unlikely, demand won't return to pre-pandemic levels until 2023and could peak earlier than previously thought.\nAfter the prior two weeks of record-breaking swings in inventories, this last week is expected to show only modest changes, with crude stocks sitting at their highest since early December.\nSource: Bloomberg\nAPI\n\nCrude -1.00mm (+400k exp)\nCushing\nGasoline -930k (-1.4mm exp)\nDistillates +904k (-900k exp)\n\nDOE\n\nCrude +2.396mm (+400k exp)\nCushing -624k\nGasoline +472k (-1.4mm exp)\nDistillates +255k (-900k exp)\n\nDespite refinery utilization recovering from the weather chaos in Texas,crude stocks increased last week(significantly more than API and was expected).\nSource: Bloomberg\nUS Crude production has yet to accelerate along with higher prices and more rigs...\n\nSource: Bloomberg\nWTI hovered around $64.50 ahead of the official inventory data and reversed its rebound on the print...\nOn the bright side, that $3.00 nation gas price may be avoided.","news_type":1},"isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}